高度的抗抑郁药阿米素激活和降解素受体TRPV1的敏感性
Sebastian Pantke1,2, Johanna H Steinberg1, Lucas K H Weber1
1Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, 30625 Hannover, Germany.
Pharmaceuticals (Basel, Switzerland)
|April 26, 2025
概括
阿米特里普提林显示出作为神经病痛联合治疗的潜力. 这种抗抑郁药可以激活,敏感化,脱敏化和抑制TRPV1通道,这表明它可以增强局部素治疗.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经病变性疼痛影响许多患者,全身治疗通常会引起副作用.
- 局部素是一种替代品,但找到降低其剂量的辅助疗法至关重要.
研究的目的:
- 通过调节TRPV1通道,研究抗抑郁药物阿米丁是否可以作为神经性疼痛的辅助治疗剂.
主要方法:
- 在HEK293T细胞和表达人类TRPV1 (hTRPV1) 的小鼠背根团结 (DRG) 神经元上进行了贴片和成像实验.
主要成果:
- 阿米特利普提林以度依赖的方式激活hTRPV1,强化对素,热和质子的反应,并使hTRPV1对素变得不敏感.
- 阿米特利普提林还抑制了素激活的电流,并表现出局部麻醉特性.
结论:
- 阿米特利普提林对TRPV1表现出复杂的调节作用,包括激活,敏感化,脱敏化和抑制.
- 这些发现表明,阿米特利普提林是局部素治疗神经病痛的有希望的补充剂.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
9.4K
08:35A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
14.7K
相关概念视频
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Thermosensation
30.2K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
30.2K
Drugs Affecting Neurotransmitter Release or Uptake
867
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
867
Analgesia and Pain Management
397
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
397
GPCR Desensitization
5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
227
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
227
